|

Selinexor Tablets Clinical Trials

2 actively recruiting trials

▲ +1 trial since August 2026

Also known as: S

Pipeline

Phase 3: 2

Top Sponsors

  • Innovent Biologics (Suzhou) Co. Ltd.1
  • Chengdu Zenitar Biomedical Technology Co., Ltd1

Indications

  • Cancer2
  • Relapsed or Refractory Multiple Myeloma1
  • Recurrent and Refractory Diffuse Large B-cell Lymphoma1

Other2 trials

A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma
Phase 3
A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.